<img alt="Business Insider Journal" data-src="//businessinsiderjournal.com/wp-content/uploads/2023/07/Logo-5.png" class="img-fluid lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img-fluid" src="//businessinsiderjournal.com/wp-content/uploads/2023/07/Logo-5.png" alt="Business Insider Journal">

RAD 202 receives approval to start Phase 1 therapeutic trial

Stock
December 20, 2024

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

© 2019, Digiqole. All rights reserved